Latest Breaking News On - Daniel silvers - Page 1 : comparemela.com

MRC Global (MRC) Appoints Daniel Silvers to its Board

MRC Global Announces Agreement with Engine Capital and Appointment of Daniel Silvers to the Board of Directors

HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) MRC Global Inc. (NYSE: MRC) (“MRC Global” or the “Company”), the leading global distributor of pipe, valves and fittings (PVF) and other infrastructure products and services to diversified gas utility, energy and industrial end-markets, today announced that Daniel Silvers has been appointed to the Company’s Board of Directors, effective immediately. Mr. Silvers will serve on the Board’s Compensation and Environmental, Social, Governance and Enterprise

MRC Global Announces Agreement with Engine Capital and Appointment of Daniel Silvers to the Board of Directors - Inspired Entertainment (NASDAQ:INSE), MRC Global (NYSE:MRC)

HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) MRC Global Inc. (NYSE:MRC) ("MRC Global" or the "Company"), the leading global distributor of pipe, valves and fittings (PVF) and other infrastructure products and services

Leisure Acquisition Corp. Announces Receipt of and Plan to Appeal Nasdaq Listing Determination

/PRNewswire/ Leisure Acquisition Corp. ("LACQ" or the "Company") (Nasdaq: LACQ, LACQU, LACQW), a special purpose acquisition company formed for the purpose.

Ensysce Biosciences, Inc. And Leisure Acquisition Corp. Announce Appointment Of Dave Humphrey As Chief Financial Officer

Share this article Share this article NEW YORK and SAN DIEGO, Feb. 18, 2021 /PRNewswire/ Ensysce Biosciences Inc. ( Ensysce ), a clinical stage pharmaceutical company developing medicines for severe pain relief to reduce fear of addiction, opioid misuse, abuse and overdose, and Leisure Acquisition Corp. (NASDAQ: LACQ) ( LACQ ) today announced the appointment of David Humphrey to Ensysce s management team as its Chief Financial Officer. Mr. Humphrey brings over 20 years of experience with development-stage companies as they progress toward product commercialization. Prior to joining Ensysce, Mr. Humphrey was Chief Financial Officer of Senomyx, Inc., a publicly-held biotechnology company which he led through an acquisition by Firmenich SA, a private Swiss multinational flavor and fragrance company.  As part of his responsibilities, he will oversee financial strategy and business expansion at Ensysce, in addition to assisting with Ensysce s proposed business combination with LA